他克莫司可能与戊酸倍他米松一样有效（一种有效的类固醇）。
Tacrolimus is probably as strong as betamethasone valerate (a potent steroid).
他克莫司患者中有11.7％的患者出现ACR70反应，而米唑瑞滨患者则没有。
11.7% of the tacrolimus patients had an ACR70 response compared with none of the mizoribine patients.
这些病是由硝呋莫司寄生虫引起的。
采用逆相蒸发法制备洛莫司汀脂质体。
Lomustine liposomes were prepared by the reversed-phase evaporation method.
目的确立阿昔莫司胶囊溶出度测定方法。
Objective To establish the assay method of dissolution rate on Acipimox Capsules.
目的合成卡莫司汀。
目的探讨他克莫司对移植肝脏再灌注损伤的影响。
Objective to investigate the effects of tacrolimus on reperfusion injury in orthotopic liver transplantation.
FDA正在酝酿是否需要修改西罗莫司的标签信息。
The FDA is determining whether a labeling change for sirolimus is needed.
严重的腹泻在联合用药组的发生率高于依维莫司组。
Severe diarrhea occurred at a higher frequency in the combination group than in the everolimus group.
他克莫司是一种用于器官移植患者的重要免疫抑制剂。
Tacrolimus is an important immunosuppressive drug for organ transplantation patients.
眼镜框过敏性接触性皮炎：他克莫司可以预防复发吗？
Eyeglass frame allergic contact dermatitis: Does tacrolimus prevent recurrences?
结果及结论此方法合成卡莫司汀原料易得，操作方便。
Results and conclusion This way to produce Carmustine is easy to operate and the raw materials are easily obtained.
目的：观察他克莫司软膏对激素依赖性皮炎的治疗作用。
Objective To observe the effectiveness of Tacrolimus Ointment on corticosteroid-dependent dermitis.
目的探讨盐酸雷莫司琼注射液安全性，为临床用药提供参考。
Objective It's to provide reference for clinical utilization that the safety of ramosetron hydrochloride injection was studied.
目的探讨各因素对他克莫司温度敏感眼用凝胶体外释放的影响。
Objective to study the factors that influence the release of tacrolimus from the thermosensitive ophthalmic gel.
结论他克莫司软膏外用治疗寻常型银屑病具有良好疗效和安全性。
Conclusion Tacrolimus ointment is effective, safe and tolerable in the topical treatment of psoriasis vulgaris.
蛋白尿症与肾小球的病变以及西罗莫司(免疫抑制剂)的使用相关。
Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus.
西罗莫司用于在13岁及以上接受肾移植患者中预防器官排斥反应。
Sirolimus is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving kidney transplants.
苯达莫司汀是一种新的化疗药物，可以增强我们对抗这种疾病的能力。
Bendamustine is a new chemotherapy drug that has expanded the ability to fight this disease.
目的：探讨卡莫司汀对人脑肿瘤干细胞在细胞增殖及细胞周期方面的影响。
Objective To investigate the effects of BCNU on the proliferation and cell cycle of stem cells from human brain tumor.
目的：评价0.03%他克莫司软膏治疗儿童特应性皮炎的疗效和安全性。
Objective: to evaluate the efficacy and safety of 0.03% tacrolimus ointment in the treatment of atopic dermatitis in children.
该小组也报道指出停用吡美莫司乳膏并不会导致随访期患者皮肤症状反弹。
Stopping pimecrolimus cream did not lead to a rebound of skin symptoms in most of the patients who entered the follow-up phase, they also report.
在西罗莫司组中因不良事件而导致停药的也多于继续使用CNI治疗的患者。
Drug discontinuation due to an adverse event was also more frequent in the sirolimus cohort compared to those patients continued on CNI.
因此，监测他克莫司血药浓度非常重要，因为可判断临床疗效、避免毒副作用。
Hence, it is of the utmost importance to monitor tacrolimus blood concentration, thereby ensuring clinical effect and avoiding toxic side effects.
在向FDA申报批准的临床研究中，大部分病人都对苯达莫司汀和利妥昔单抗耐药。
In the study that led to the FDA approval, most patients were refectory to bendamustine and rituximab.
这项先导试验是设计用来评估西罗莫司用于肾功不全肝移植受体的安全性和有效性的。
This pilot trial was designed to assess the safety and efficacy of SRL in liver transplant recipients with renal dysfunction.
目的：分析器官移植术后应用他克莫司免疫抑制所致不良反应的临床特征和相关因素。
Objective: to study the clinical characteristics and the related factors of the adverse drug reactions (ADRs) caused by Tacrolimus after organ transplantation.
已报道有关利妥昔单抗的毒性表皮坏死，但毒性表皮坏死和苯达莫司汀的关系尚不确定。
Toxic epidermal necrolysis has been reported for rituximab, but the relationship of toxic epidermal necrolysis to bendamustine has not been determined.
再次血运重建率在西罗莫司和紫杉醇的两个临床试验类似，分别为5.6%和5.3%。
Revascularization rates were similar with the sirolimus - and paclitaxel-eluting stents in the two trials, at 5.6% versus 5.3%, respectively.
再次血运重建率在西罗莫司和紫杉醇的两个临床试验类似，分别为5.6%和5.3%。
Revascularization rates were similar with the sirolimus - and paclitaxel-eluting stents in the two trials, at 5.6% versus 5.3%, respectively.
应用推荐